← Evidence map

TrialInternational journal of nephrology and renovascular disease2026

Effectiveness and Safety of Telmisartan Plus Amlodipine Compared to Telmisartan Plus Cilnidipine in Indian Patients with Hypertension and Renal Impairment: A Randomized, Open Label, Post Marketing Study (START Renal).

Uday Jadhav et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Effectiveness and Safety of Telmisartan Plus Amlodipine Compared to Telmisartan Plus Cilnidipine in Indian Patients with Hypertension and Renal Impairment: A Randomized, Open Label, Post Marketing Study (START Renal). | Socratic